Diageo Restates Regional Financials for FY25 and FY26
DEO sits 26% above its 52-week low of $72.45.
Summary
Diageo published restated regional financial results for fiscal 2025 and 2026, aligning external reporting with a new operating framework effective fiscal 2027.
Key Events · Corporate Governance and Compliance · DEO
-
Regional Financial Restatement
Historical regional financial results for fiscal years ended 30 June 2025 and 30 June 2026 have been restated.
-
New Operating Framework
External reporting is now aligned with a new market and regional operating framework effective fiscal 2027.
-
Prior Financial Turbulence
This follows August 2026 disclosures of $1.5B impairments, a $19B parent investment write-down, and a dividend cut.
-
Investor Impact
Changes to regional segmentation may affect comparability and how investors evaluate segment performance.
Analysis · DEO · Manufacturing
A material restatement of previously reported financial data warrants close investor attention. Diageo has restated its historical regional financial results for fiscal years 2025 and 2026 to align with a new market and regional operating framework effective fiscal 2027. The restatement follows a period of significant financial turbulence, including $1.5B in impairments, a $19B parent investment write-down, and a dividend cut disclosed in August 2026. The new regional framework may change how investors evaluate segment performance and could affect comparability with prior periods.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DEO was trading at $91.24 on NYSE in the Manufacturing sector, with a market capitalization of approximately $49.2B. The 52-week trading range was $72.45 to $102.74. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.